Logo image of ELES.MI

ELES SEMICONDUCTOR EQUIPMENT (ELES.MI) Stock Fundamental Analysis

BIT:ELES - Euronext Milan - IT0005373417 - Common Stock - Currency: EUR

1.49  -0.03 (-1.97%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ELES. ELES was compared to 58 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of ELES is average, but there are quite some concerns on its profitability. ELES has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ELES was profitable.
In the past year ELES had a positive cash flow from operations.
ELES had positive earnings in each of the past 5 years.
In multiple years ELES reported negative operating cash flow during the last 5 years.
ELES.MI Yearly Net Income VS EBIT VS OCF VS FCFELES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M 3M

1.2 Ratios

ELES's Return On Assets of 1.51% is on the low side compared to the rest of the industry. ELES is outperformed by 82.76% of its industry peers.
Looking at the Return On Equity, with a value of 3.04%, ELES is doing worse than 77.59% of the companies in the same industry.
The Return On Invested Capital of ELES (5.56%) is worse than 65.52% of its industry peers.
ELES had an Average Return On Invested Capital over the past 3 years of 3.17%. This is significantly below the industry average of 16.14%.
The 3 year average ROIC (3.17%) for ELES is below the current ROIC(5.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.51%
ROE 3.04%
ROIC 5.56%
ROA(3y)1.63%
ROA(5y)2.67%
ROE(3y)3.51%
ROE(5y)5.78%
ROIC(3y)3.17%
ROIC(5y)3.51%
ELES.MI Yearly ROA, ROE, ROICELES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

ELES has a Profit Margin of 2.47%. This is amonst the worse of the industry: ELES underperforms 82.76% of its industry peers.
ELES's Profit Margin has declined in the last couple of years.
ELES has a Operating Margin of 10.23%. This is in the lower half of the industry: ELES underperforms 72.41% of its industry peers.
In the last couple of years the Operating Margin of ELES has grown nicely.
The Gross Margin of ELES (48.00%) is comparable to the rest of the industry.
ELES's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.23%
PM (TTM) 2.47%
GM 48%
OM growth 3Y3.37%
OM growth 5Y7.47%
PM growth 3Y-36.02%
PM growth 5Y-6.42%
GM growth 3Y6.79%
GM growth 5Y4.3%
ELES.MI Yearly Profit, Operating, Gross MarginsELES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELES is destroying value.
Compared to 1 year ago, ELES has more shares outstanding
ELES has more shares outstanding than it did 5 years ago.
ELES has a better debt/assets ratio than last year.
ELES.MI Yearly Shares OutstandingELES.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ELES.MI Yearly Total Debt VS Total AssetsELES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.00 indicates that ELES is not a great score, but indicates only limited risk for bankruptcy at the moment.
ELES's Altman-Z score of 2.00 is on the low side compared to the rest of the industry. ELES is outperformed by 79.31% of its industry peers.
ELES has a debt to FCF ratio of 2.92. This is a good value and a sign of high solvency as ELES would need 2.92 years to pay back of all of its debts.
ELES has a Debt to FCF ratio (2.92) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.34 indicates that ELES is not too dependend on debt financing.
ELES has a Debt to Equity ratio (0.34) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.92
Altman-Z 2
ROIC/WACC0.57
WACC9.79%
ELES.MI Yearly LT Debt VS Equity VS FCFELES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M 25M

2.3 Liquidity

ELES has a Current Ratio of 2.18. This indicates that ELES is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ELES (2.18) is worse than 60.34% of its industry peers.
A Quick Ratio of 1.50 indicates that ELES should not have too much problems paying its short term obligations.
ELES has a Quick ratio (1.50) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.18
Quick Ratio 1.5
ELES.MI Yearly Current Assets VS Current LiabilitesELES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

ELES shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.01%.
The earnings per share for ELES have been decreasing by -11.74% on average. This is quite bad
ELES shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.73%.
The Revenue has been growing by 8.13% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.01%
EPS 3Y-30.53%
EPS 5Y-11.74%
EPS Q2Q%0%
Revenue 1Y (TTM)9.73%
Revenue growth 3Y21.88%
Revenue growth 5Y8.13%
Sales Q2Q%5.01%

3.2 Future

Based on estimates for the next years, ELES will show a very strong growth in Earnings Per Share. The EPS will grow by 26.72% on average per year.
The Revenue is expected to grow by 10.34% on average over the next years. This is quite good.
EPS Next Y-14.29%
EPS Next 2Y19.52%
EPS Next 3Y25.99%
EPS Next 5Y26.72%
Revenue Next Year7.14%
Revenue Next 2Y10.6%
Revenue Next 3Y10.72%
Revenue Next 5Y10.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ELES.MI Yearly Revenue VS EstimatesELES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ELES.MI Yearly EPS VS EstimatesELES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.05 0.1 0.15

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.80, which means the current valuation is very expensive for ELES.
ELES's Price/Earnings ratio is a bit more expensive when compared to the industry. ELES is more expensive than 60.34% of the companies in the same industry.
When comparing the Price/Earnings ratio of ELES to the average of the S&P500 Index (29.35), we can say ELES is valued inline with the index average.
ELES is valuated correctly with a Price/Forward Earnings ratio of 14.61.
75.86% of the companies in the same industry are more expensive than ELES, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ELES is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 29.8
Fwd PE 14.61
ELES.MI Price Earnings VS Forward Price EarningsELES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELES is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
ELES's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ELES is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.74
EV/EBITDA 5.06
ELES.MI Per share dataELES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ELES's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.52%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

ELES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELES SEMICONDUCTOR EQUIPMENT

BIT:ELES (3/4/2025, 7:00:00 PM)

1.49

-0.03 (-1.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.46%
Inst Owner ChangeN/A
Ins Owners31.74%
Ins Owner ChangeN/A
Market Cap25.39M
Analysts82.86
Price Target3.18 (113.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 29.8
Fwd PE 14.61
P/S 0.76
P/FCF 4.74
P/OCF 4.19
P/B 0.93
P/tB 1.55
EV/EBITDA 5.06
EPS(TTM)0.05
EY3.36%
EPS(NY)0.1
Fwd EY6.85%
FCF(TTM)0.31
FCFY21.09%
OCF(TTM)0.36
OCFY23.87%
SpS1.97
BVpS1.6
TBVpS0.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 3.04%
ROCE 8.84%
ROIC 5.56%
ROICexc 6.92%
ROICexgc 10.58%
OM 10.23%
PM (TTM) 2.47%
GM 48%
FCFM 15.98%
ROA(3y)1.63%
ROA(5y)2.67%
ROE(3y)3.51%
ROE(5y)5.78%
ROIC(3y)3.17%
ROIC(5y)3.51%
ROICexc(3y)4.38%
ROICexc(5y)5.23%
ROICexgc(3y)6.48%
ROICexgc(5y)7.65%
ROCE(3y)5.04%
ROCE(5y)5.57%
ROICexcg growth 3Y-3.19%
ROICexcg growth 5Y-13.57%
ROICexc growth 3Y-4.03%
ROICexc growth 5Y-10.63%
OM growth 3Y3.37%
OM growth 5Y7.47%
PM growth 3Y-36.02%
PM growth 5Y-6.42%
GM growth 3Y6.79%
GM growth 5Y4.3%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.92
Debt/EBITDA 1.52
Cap/Depr 25.93%
Cap/Sales 2.1%
Interest Coverage 250
Cash Conversion 98.6%
Profit Quality 646.74%
Current Ratio 2.18
Quick Ratio 1.5
Altman-Z 2
F-Score7
WACC9.79%
ROIC/WACC0.57
Cap/Depr(3y)36.52%
Cap/Depr(5y)31.08%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.01%
EPS 3Y-30.53%
EPS 5Y-11.74%
EPS Q2Q%0%
EPS Next Y-14.29%
EPS Next 2Y19.52%
EPS Next 3Y25.99%
EPS Next 5Y26.72%
Revenue 1Y (TTM)9.73%
Revenue growth 3Y21.88%
Revenue growth 5Y8.13%
Sales Q2Q%5.01%
Revenue Next Year7.14%
Revenue Next 2Y10.6%
Revenue Next 3Y10.72%
Revenue Next 5Y10.34%
EBIT growth 1Y44.17%
EBIT growth 3Y25.99%
EBIT growth 5Y16.21%
EBIT Next Year125%
EBIT Next 3Y48.12%
EBIT Next 5Y38.83%
FCF growth 1Y317.24%
FCF growth 3Y-21.79%
FCF growth 5Y-1.19%
OCF growth 1Y403%
OCF growth 3Y-6.83%
OCF growth 5Y4.63%